ESTIMATION OF LIPID PROFILE AND ASSESSMENT OF CARDIOVASCULAR RISK IN SMOKERS BY USING NEW ATHEROGENIC INDICES
Abstract
Objective: Smoking habit leads to elevated levels of lipid profile thus increasing the cardiovascular disease risk in coronary heart disease. The aim of
study is undertaken to evaluate plasma lipid profile, of the male smoker with non-smoker's healthy matched control and assessing the cardiovascular
risk by using new atherogenic indices.
Methods: Fasting blood samples were collected form both cases and controls and estimation of lipid profile by using by using autoanalyzer. A detailed
physical and anthropometric parameters information was collected form each participant subjects.
Results: Plasma total cholesterol (TC) (221.52±8.34), triglyceride (TG) (274.94±28.70) low density lipoprotein cholesterol (LDL-c) (129.22±7.76),
very LDL-c (VLDL-c) (54.98±5.74) and non-high-density lipoprotein cholesterol NonHDL-c (HDL-c) (183.26±7.58) in smokers subjects, which were
significantly (p<0.0001) higher compared with non-smokers, while HDL-c significantly (38.25±1.34; p<0.001) decreased in smokers as compared
to non-smokers. Further, atherogenic ratios like, Castelli's risk index (CRI-I)=TC/HDL-c, CRI-II=LDL-c/HDL-c, atherogenic coefficient = (TC–HDL-c)/
HDL-c TG/HDL-c ratio, and atherogenic index of plasma =log (TG/HDL-c) were calculated for individual subjects by using lipid profile. All these lipid
ratio are significantly (p<0.0001) in smoker group.
Conclusion: Our conclusion, these ratio's could be used for identifying individual at higher risk of cardiovascular disease in the clinical practices
especially, when the absolute values of lipid profile seem normal or higher and not markedly deranged or in centers with insufficient resources.
Keywords: Cigarette smoking, Lipid profile, Cardiovascular risk, Atherogenic indices.
Downloads
References
Ghannem H, Harrabi I, Ben AA, Gaha R, Trabelsi L. Smoking habits and cardiovascular risk factors among adolescents in sousse, Tunisia. Arch Public Health 2003;61:151-60.
Wynder EL, Harris RE, Haley NJ. Population screening for plasma cholesterol: Community-based results from Connecticut. Am Heart J 1989;117(3):649-56.
Department of Health and Human Services. The Health Benefits of Smoking Cessation. Surgeon General’s Report on Smoking and Health. Atlanta: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. DHHS Publication No. (CDC); 1990. p. 90-8416.
Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park heart study. Lancet 1993;342(8879):1076-9.
Miller GJ, Bauer KA, Cooper JA, Rosenberg RD. Activation of the coagulant pathway in cigarette smokers. Thromb Haemost 1998;79(3):549-53.
Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, Stein JH. Effects of smoking and smoking cessation on lipids and lipoproteins: Outcomes from a randomized clinical trial. Am Heart J 2011;161(1):145‑51.
Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991;11(1):2-14.
Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004;43(10):1731‑7.
Kavita SG, Meeta GN, Priyanka MG, Gonsa RN. Effects of smoking on lipids profile. Jt Comm Rural Reconstr 2013;5:36-42.
Muscat JE, Harris RE, Haley NJ, Wynder EL. Cigarette smoking and plasma cholesterol. Am Heart J 1991;121:141-7.
Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: Potential implications for clinical guidelines. Circulation 2004;110(18):2824-30.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499-502.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-421.
Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983;67(4):730-4.
Brehm A, Pfeiler G, Pacini G, Vierhapper H, Roden M. Relationship between serum lipoprotein ratios and insulin resistance in obesity. Clin Chem 2004;50(12):2316-22.
Frohlich J, Dobiásová M. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem 2003;49(11):1873-80.
da Luz PL, Favarato D, Faria-Neto JR Jr, Lemos P, Chagas AC. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics (Sao Paulo) 2008;63(4):427-32.
Dobiásová M. Atherogenic index of plasma [log (triglycerides/HDL-cholesterol)]: Theoretical and practical implications. Clin Chem 2004;50(7):1113-5.
Haslam DW, James WP. Obesity. Lancet 2005;366(9492):1197-209.
Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L, et al. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann Intern Med 2003;138(1):24-32.
Freedman DM, Sigurdson AJ, Rajaraman P, Doody MM, Linet MS, Ron E. The mortality risk of smoking and obesity combined. Am J Prev Med 2006;31(5):355-62.
Ezzati M, Lopez AD. Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control 2004;13(4):388-95.
Alharbi WD. Influence of cigarette smoking on lipid profile in male university students. Pak J Pharmacol 2011;28(2):45-9.
Venkatesan A, Hemalatha A, Bobby Z, Selvaraj N, Sathiyapriya V. Effect of smoking on lipid profile and lipid peroxidation in normal subjects. Indian J Physiol Pharmacol 2006;50(3):273-8.25. Rastogi R, Shrivastava SS, Mehrotra TN, Singh VS, Gupta MK. Lipid profile in smokers. J Assoc Physicians India 1989;37(12):764-6.
Sinha AK, Misra GC, Patel DK. Effect of cigarette smoking on lipid profile in the young. J Assoc Physicians India 1995;43(3):185-8.
Krupski WC. The peripheral vascular consequences of smoking. Ann Vasc Surg 1991;5(3):291-304.
Quillen JE, Rossen JD, Oskarsson HJ, Minor RL Jr, Lopez AG, Winniford MD. Acute effect of cigarette smoking on the coronary circulation: Constriction of epicardial and resistance vessels. J Am Coll Cardiol 1993;22(3):642-7.
Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295(11):573‑7.
Hung J, Lam JY, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995;92(9):2432-6.
Neki NS. Lipid profile in chronic smokers: A clinical study. J Indian Acad Clin Med 2002;3(1):51-4.
Benowitz NL. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319(20):1318-30.
Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320(14):915-24.
Bloomer RJ. Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarette smokers compared to nonsmokers: Impact of dietary intake. Nutr J 2007;6:39.
Kharb S, Singh GP. Effect of smoking on lipid profile, lipid peroxidation and antioxidant status in normal subjects and in patients during and after acute myocardial infarction. Clin Chim Acta 2000;302(1-2):213‑9.
Pittilo RM. Cigarette smoking and endothelial injury: A review. Adv Exp Med Biol 1990;273:61-78.
Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362(6423):801-9.
Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999;340(2):115-26.
Kilim SR, Chandala SR. Lipid profile and oestradiol in pre - and post-menopausal women. J Clin Diagn Res 2013;7(8):1596-8.
Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986;256(20):2835‑8.
Subia J, Afshan S. Comparison of CVD risk associated with the long term use of contraceptives in young females. J Appl Pharm Sci 2012;2(11):062-6.
Nair D, Carrigan TP, Curtin RJ, Popovic ZB, Kuzmiak S, Schoenhagen P, et al. Association of total cholesterol/high-density lipoprotein cholesterol ratio with proximal coronary atherosclerosis detected by multislice computed tomography. Prev Cardiol 2009;12(1):19-26.
Assmann G, Cullen P, Schulte H. The munster heart study (PROCAM). Results of follow - up at 8 years. Eur Heart J 1998;19 Suppl A: A2-11.
Packard CJ, Shepherd J. Lipoprotein heterogenity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 1999;19:2456-64.
Brinton EA, Eeisenberg S, Breslow JL. Increased apo A-I and apo-AII fractional catabolic rate in patients with low high density lipoprotein - cholesterol levels with or without hypertriglyceridemia. J Clin Invest 1991;87:536-44.
Gaziano JM, Hennekens CH, O’Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 1997;96(8):2520-5.
Bampi AB, Rochitte CE, Favarato D, Lemos PA, da Luz PL. Comparison of non-invasive methods for the detection of coronary atherosclerosis. Clinics (Sao Paulo) 2009;64(6):675-82.
Dobiásová M. AIP – atherogenic index of plasma as a significant predictor of cardiovascular risk: From research to practice. Vnitr Lek 2006;52(1):64-71.
Usoro CA, Adikwuru CC, Usoro IN, Nsonwu AC. Lipid profile of postmenopausal women in calabar, Nigeria. Pak J Nutr 2006;5:79-82.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.